The Value of Tissue Expression as a Predictor of Efficacy for First or Second-Line Therapy in Metastatic Ductal Pancreas Cancer in Patients Receiving either Gemcitabine Based Therapy or 5FU Based Therapy

Lauren Carcas

The Value of Tissue Expression as a Predictor of Efficacy for First or Second-Line Therapy in Metastatic Ductal Pancreas Cancer in Patients Receiving either Gemcitabine Based Therapy or 5FU Based Therapy

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Jun 25 2014
Event	Hematology/Oncology Grand Rounds, University of Miami - Duration: Jun 25 2014 → …

Conference

Conference	Hematology/Oncology Grand Rounds, University of Miami
Period	6/25/14 → …

Disciplines

Medicine and Health Sciences

Cite this

@conference{02b5334fc2ec452b9c7d47f34afd873b,

title = "The Value of Tissue Expression as a Predictor of Efficacy for First or Second-Line Therapy in Metastatic Ductal Pancreas Cancer in Patients Receiving either Gemcitabine Based Therapy or 5FU Based Therapy",

author = "Lauren Carcas",

year = "2014",

month = jun,

day = "25",

language = "American English",

note = "Hematology/Oncology Grand Rounds, University of Miami ; Conference date: 25-06-2014",

}

TY - CONF

T1 - The Value of Tissue Expression as a Predictor of Efficacy for First or Second-Line Therapy in Metastatic Ductal Pancreas Cancer in Patients Receiving either Gemcitabine Based Therapy or 5FU Based Therapy

AU - Carcas, Lauren

PY - 2014/6/25

Y1 - 2014/6/25

M3 - Presentation

T2 - Hematology/Oncology Grand Rounds, University of Miami

Y2 - 25 June 2014

ER -